Wanbury Limited has announced the appointment of Mr. Prakash Venkatraman as President of the API business. With a stellar career spanning over three decades, Mr. Venkatraman brings a wealth of experience in API operations, P&L management, and business strategy.
Mr. Venkatraman holds a Bachelor's degree in Chemical Engineering and a Master's degree in Management Studies from Mumbai University.
Mr. Venkatraman most recently served as Senior Vice President of the API business at Shilpa Pharma Lifesciences for over 3 years. In this role, he spearheaded the API division, driving growth and delivering on revenue and EBITDA targets.
Previously, Mr. Venkatraman led Global Sales and Business Development for Sun Pharma's API division as Senior Vice President. Mr. Venkatraman spent 8 years at Jubilant Life Sciences as Senior Vice President of the API business establishing Jubilant as a global leader in specific molecules and expanding capacity to meet surging demand.
Mr. Venkatraman's career also includes senior leadership roles at Wockhardt, Ranbaxy, and Kopran, where he consistently delivered on organizational objectives.
Wanbury Limited is confident that Mr. Venkatraman's strong leadership, problem-solving skills, and strategic vision will elevate our success and significantly contribute to achieving our business goals and objectives.
Shares of Wanbury Limited was last trading in BSE at Rs. 178.70 as compared to the previous close of Rs. 183.70. The total number of shares traded during the day was 20331 in over 769 trades.
The stock hit an intraday high of Rs. 184.70 and intraday low of 174.60. The net turnover during the day was Rs. 3631552.00.